Retrospective Study
Copyright ©The Author(s) 2017.
World J Nephrol. Jul 6, 2017; 6(4): 201-208
Published online Jul 6, 2017. doi: 10.5527/wjn.v6.i4.201
Table 1 Patient characteristics n (%)
Two clearance studiesThree clearance studiesFour clearance studies
Patient number1668444
Age at onset of peritoneal dialysis, yr52 ± 1551 ± 1651 ± 18
Male94 (56.6)46 (54.8)26 (59.1)
Female72 (43.4)38 (45.2)18 (40.9)
Diabetic nephropathy73 (44.0)36 (42.9)17 (38.6)
Table 2 Creatinine excretion in patients with two studies
Variable1st clearance study2nd clearance studyP value
PD duration, mo9.2 ± 15.217.4 ± 15.8
VU, L/24-h0.54 ± 0.630.40 ± 0.53< 0.001
VD, L/24-h11.3 ± 3.212.1 ± 3.6NS
Kt/V urea, weekly2.30 ± 0.622.12 ± 0.030.003
CCr, L/1.73 m2, weekly77.9 ± 32.167.9 ± 18.20.002
SUN, mg/dL49.7 ± 15.149.4 ± 16.2NS
[Cr]S, mg/dL9.1 ± 3.310.1 ± 3.40.001
EXCr U, mg/24-h406 ± 337286 ± 3500.003
EXCr D, mg/24-h680 ± 337769 ± 390< 0.001
EXCr T, mg/24-h1087 ± 4701055 ± 421NS
Table 3 Creatinine excretion in patients with three studies
Variable1st clearance study2nd clearance study3rd clearance studyP value
PD duration, mo8.6 ± 7.816.8 ± 11.624.7 ± 16.3
VU, L/24-h0.58 ± 0.660.45 ± 0.590.38 ± 0.500.0001
VD, L/24-h11.5 ± 4.011.8 ± 3.712.4 ± 3.7NS
Kt/V urea, weekly2.28 ± 0.652.14 ± 0.582.12 ± 0.630.0245
CCr, L/1.73 m2, weekly79.3 ± 35.671.4 ± 27.868.0 ± 26.90.0335
SUN, mg/dL50.4 ± 18.549.5 ± 17.949.2 ± 19.2NS
[Cr]S, mg/dL9.5 ± 3.59.8 ± 3.410.1 ± 3.30.0066
EXCr U, mg/24-h418 ± 404370 ± 425286 ± 362< 0.0001
EXCr D, mg/24-h731 ± 379767 ± 396779 ± 382NS1
EXCr T, mg/24-h1149 ± 4161137 ± 4541065 ± 4420.0087
Table 4 Creatinine excretion in patients with four clearance studies
Variable1st clearance study2nd clearance study3rd clearance study4th clearance studyP value
PD duration, mo8.1 ± 12.616.5 ± 4.424.5 ± 16.331.9 ± 16.8
VU, L/24-h0.54 ± 0.550.41 ± 0.490.33 ± 0.400.29 ± 0.42< 0.0001
VD, L/24-h11.8 ± 3.912.2 ± 3.612.2 ± 3.512.5 ± 3.2NS
Kt/V urea, weekly2.27 ± 0.652.15 ± 0.562.13 ± 0.542.10 ± 0.550.0356
CCr, L/1.73 m2, weekly77.5 ± 29.770.4 ± 28.568.5 ± 25.766.1 ± 22.10.0238
SUN, mg/dL49.8 ± 16.749.5 ± 15.449.2 ± 15.349.0 ± 13.5NS
[Cr]S, mg/dL9.8 ± 3.610.2 ± 3.710.8 ± 3.810.8 ± 3.60.0009
EXCr U, mg/24-h411 ± 438382 ± 460272 ± 345282 ± 4810.0011
EXCr D, mg/24-h755 ± 406788 ± 424808 ± 438853 ± 3980.0021
EXCr T, mg/24-h1166 ± 4401170 ± 4951080 ± 4551135 ± 521NS
Table 5 Number (percent) of studies with creatinine excretion deviating from baseline by < 15% and ≥ 15%
Study< 15% from the 1st study≥ 15% above the 1st study≥ 15% below the 1st study
Second90 (54.2%)41 (24.7%)35 (21.1%)
Third40 (47.6%)28 (33.3%)16 (19.1%)
Fourth24 (54.5%)11 (25.0%)9 (20.5%)